-
Mashup Score: 13Prognostic Implications of N-terminal Pro-B Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved: - 2 year(s) ago
Abstract Background N-terminal pro-B type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) are associated with disease severity and outcomes among patients with hea…
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry - 2 year(s) ago
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). Methods Data were collected prospectively into the Sheffield HEArt Failure…
Source: Open HeartCategories: Cardiologists, Latest HeadlinesTweet-
CV medication in patients with raised #NTproBNP, but no #HeartFailure in the Sheffield HF (SHEAF) registry 1766 pts with ⬆️ #NT-proBNP with no evidence of #HF on #TTE Mortality was ⬆️ with 🧔♂️ gender, VHDs and #CKD https://t.co/H8B53D74uZ @Open_HeartBMJ @Heart_BMJ @mmamas1973 https://t.co/1YHif2jfC8
-
-
Mashup Score: 1Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome - 2 year(s) ago
Elevated N-terminal pro-B-type natriuretic peptides (NT-proBNP) and cardiac troponin T (cTnT) and are associated with poor outcome in patients with chronic coronary syndrome (CCS). The performance of these biomarkers in diagnosing ischemia, and their association with myocardial hypoperfusion and hypokinesis is unclear.
Categories: Cardiologists, Latest HeadlinesTweet-
This finding may suggest that the functional effects of myocardial ischemia may be a stronger stimulus for release of cTnT and proBNP than ischemia per se #cTnT and #NTproBNP performed better than exercise stress ECG in discriminating for ischemia https://t.co/vR4tag6enZ @pmyhre https://t.co/tzctUkIwPW
-
-
Mashup Score: 2Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome - 2 year(s) ago
Elevated N-terminal pro-B-type natriuretic peptides (NT-proBNP) and cardiac troponin T (cTnT) and are associated with poor outcome in patients with chronic coronary syndrome (CCS). The performance of these biomarkers in diagnosing ischemia, and their association with myocardial hypoperfusion and hypokinesis is unclear.
Categories: Cardiologists, Latest HeadlinesTweet-
cTnT and NTproBNP for detecting myocardial ischemia in suspected CCS #cTnT and #NTproBNP are associated with irreversible and reversible ischemia in patients with suspected #CCS, particularly hypokinesis https://t.co/vR4tag6enZ @pmyhre @ThorEdvardsen @JJheart_doc @mvaduganathan https://t.co/7eOPZWZFii
-
-
Mashup Score: 3
AbstractBackground. A substantial proportion of patients with heart failure (HF) with preserved ejection fraction (HFpEF) present with normal natriuretic peptid
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
#HF with preserved #EF in patients with normal #NTproBNP levels is associated with increased #MACE https://t.co/VvqB5De9qR
-
-
Mashup Score: 8
AbstractBackground. A substantial proportion of patients with heart failure (HF) with preserved ejection fraction (HFpEF) present with normal natriuretic peptid
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Quite possibly the most important paper of my career so far @ESC_Journals One sentence summary: No cut-off for #NTproBNP is low enough to exclude clinically meaningful #HeartFailure! Another one from the Barry Borlaug lab @yreddyhf https://t.co/lO9L8d6ThZ Thread below...
-
-
Mashup Score: 3
Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin angiote
Source: CirculationCategories: Cardiac Surgery, Latest HeadlinesTweet-
4/5 Median time after AMI was 3.6 y, and thus this study did not assess the effect of Sac/Val on early remodeling in the acute phase of MI. https://t.co/KAhiukkRUF #AHAJournals
-
3/5 Median #NTproBNP was 230 mg/ml, lower than most #HFrEF pts, and exploratory analysis showed sign reverse remodeling in those with #NTproBNP above median. https://t.co/KAhiukkRUF #AHAJournals https://t.co/D7SwWZ3XbI
-
2/5 No significant difference was present for the primary outcome of #LVESVI, and also the secondary #CMR and #biomarker outcomes https://t.co/KAhiukkRUF #AHAJournals https://t.co/kzHHZKMKsG
-
1/5 #RCT of 93 pts w EF<40% after #AMI, but w/o #HF: 52w #Sac/Val vs valsartan did not sign reverse cardiac remodeling or reduce #NTproBNP/#troponin. @Kieranfdocherty https://t.co/KAhiukkRUF #AHAJournals https://t.co/P5nDZrSpCy
-
-
Mashup Score: 0
NT‐proBNP is frequently elevated in patients with COVID‐19, and is strongly associated with myocardial injury and all‐cause mortality.
Source: Wiley Online LibraryCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A #HeartFailure biomarker in the risk stratification of #COVID19 patients - #NTproBNP frequently high and associated with outcome in these patients https://t.co/mjzLqCv5kV @MarcoMetra @HFA_President @kevin_damman #EJHF https://t.co/BLDH1NABq9
-
-
Mashup Score: 0
Background and Purpose: We aimed to investigate the relationship between early NT-proBNP (N-terminal probrain natriuretic peptide) and all-cause death in patients receiving reperfusion therapy, inclu
Source: StrokeCategories: Latest Headlines, NeurologyTweet-
#STROKE N-terminal probrain natriuretic peptide #NTproBNP as an independent predictor of malignant edema and 3mo mortality in patients receiving reperfusion therapy #IVtPA #MechanicalThrombectomy https://t.co/JBUDN84mud https://t.co/yg0CpP0gIr
-
-
Mashup Score: 6Biomarker-Based Risk Prediction of Incident Heart Failure in Pre-Diabetes and Diabetes: - 3 year(s) ago
Abstract Objectives This study evaluated the application of a biomarker-based risk score to identify individuals with dysglycemia who are at high risk for incident heart failure (HF) and to inform …
Source: JACC: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
New paper out today in @JACCJournals #JACCHF w/ @ambarish4786 & @_brendan_ >34M adults w T2D in US alone, ~75% without CVd. Can common biomarkers (#hsTn #NTproBNP #hsCRP #LVH) be used in risk stratification to inform cost efficient allocation of #SGLT2i? https://t.co/Bj31XhbWy0 https://t.co/c8DBjyhbfX
-
The benefit of #Empagliflozin on cardiac outcomes and decline of eGFR is preserved across the wide range of baseline #NTproBNP and hsTnT evaluated Empagliflozin modestly ⬇️ NT-proBNP in #HFpEF https://t.co/gN43446YZ6 @JACCJournals @JJHeart_doc @JavedButler1 @FaiezZANNAD #JACCHF https://t.co/gI6Japedru